TABLE 1

Baseline Clinical and Vocal Characteristics of Study Population (n = 160)

CharacteristicTotal (n = 160)TT (n = 54)TT with 1.1–2.2 GBq (n = 64)TT + ≥3.7 GBq (n = 42)P
Mean age ± SD (y)48.8 ± 10.449. 1 ± 11.247.8 ± 10.449.9 ± 9.50.558
Female (n)129 (80.6%)50 (92.6%)53 (82.9%)26 (61.9%)0.001
T stage (n)<0.001
 T1a56 (35.0%)45 (83.3%)10 (15.6%)1 (2.4%)
 T1b10 (6.2%)3 (5.6%)5 (7.8%)2 (4.8%)
 T23 (1.9%)01 (1.6%)2 (4.8%)
 T391 (56.9%)6 (11.1%)48 (75.0%)37 (88.1%)
N stage (n)<0.001
 N0102 (63.8%)52 (96.3%)43 (67.2%)7 (16.7%)
 N1a58 (36.2%)2 (3.7%)21 (32.8%)35 (83.3%)
Mean operation time ± SD (min)99.7 ± 28.6101.5 ± 23.7100.6 ± 34.996.05 ± 23.40.620
GRBAS = 0 (n)79 (49.4%)32 (59.3%)24 (37.5%)23 (54.8%)0.365
Mean acoustic ± SD
 Jitter (%)1.4 ± 1.01.4 ± 0.81.5 ± 1.01.3 ± 1.30.610
 Shimmer (%)4.0 ± 1.73.8 ± 1.64.1 ± 1.84.1 ± 1.60.875
 NHR (dB)0.1 ± 0.30.1 ± 0.00.1 ± 0.30.1 ± 0.00.162
 F0 (Hz*)198.8 ± 25.8196.1 ± 32.5201.3 ± 21.1198.9 ± 19.60.592
 VRP (Hz*)
  Fmax625.6 ± 210.4595.7 ± 199.5643.6 ± 222.5646.6 ± 206.50.441
  Fmin153.7 ± 25.0152.5 ± 27.2157.9 ± 23.1147.7 ± 23.80.217
 VHI5.0 ± 11.45.1 ± 14.05.3 ± 10.34.3 ± 9.30.413
  • NHR = noise-to-harmonic ratio.